|
PT6A posted:Safe injection sites should be as small as possible and extremely widespread, to avoid as much of the effect of concentrating drug addicts in one place as possible. I mean, what's as small as possible? Don't think it would do much good to shrink them much beyond the size of like a strip mall/business street retail slot. No point making them excessively cramped.
|
#
¿
Jan 24, 2018 22:26
|
|
|
|
| # ¿ May 12, 2024 15:00 |
|
|
sea of losers posted:this derail about trump is stupid, maybe instead of that we could look at how the FDA is getting more negatively vocal about kratom, something that could actually help ppl but isnt particularly profitable Why do you think a Pfizer or a Merck couldn't make kratom very profitable?
|
|
#
¿
Feb 8, 2018 23:02
|
|
|
sea of losers posted:they couldnt make the plant profitable. Bullshit. We live in a world where tobacco companies still make tobacco itself profitable.
|
|
#
¿
Feb 9, 2018 17:51
|
|
|
sea of losers posted:tobacco isnt sold as a medicine. Why do you think that matters?
|
|
#
¿
Feb 9, 2018 19:43
|
|
|
sea of losers posted:because the laws regarding the sale of cigarettes/alcohol and selling prescription drugs are just slightly different, and also because only certain parts of kratom may be desirable. do you see pharma companies selling raw poppy straw instead of morphine, or weed instead of marinol? So why do you think kratom can't be sold profitably? Do you think everyone selling it to you is doing it at a loss? Do you think it'll just be impossible to grow a bunch at once? You sound like the people a few decades ago who swore no one would be able to make profit on regular leaf & bud weed at the corporate scale.
|
|
#
¿
Feb 9, 2018 20:42
|
|
|
sea of losers posted:perhaps i was a little simplistic in my initial post, but my point is that if pharmaceutical companies profit off of kratom it will be through isolated chemicals or their derivatives, not the plant itself. there are tons of active alkaloids in kratom and in opium poppy, and not all of them are medically desirable in opium and i seriously doubt all of them are desirable in kratom. thebaine, for instance, is in opium poppy and can be used to make other drugs but is a terrible drug by itself. There is no reason they can't profit off just selling the leaves though. Besides you just randomly claiming they can't. Also why on earth would they need to sell it prescription??? Over the counter drugs are huge revenue sources for most pharmaceutical companies, just sell it like that in standard packages.
|
|
#
¿
Feb 9, 2018 21:21
|
|
|
sea of losers posted:i'm not "randomly claiming," i'm giving you reasons why they'd pursue chemical isolation or modification instead of selling raw leaf and yr just kinda ignoring it. what's a raw leaf product sold by a pharmaceutical company that you can think of off the top of yr head? do they sell tree bark instead of aspirin? You're not giving reasons though. If you believe people want kratom leaves, then the companies will be able to sell kratom leaves just like companies sell tobacco leaves or tea leaves or any other kind. Even though you can and sometimes fdo also sell specifically refined products of them for particular purposes. It's just the same kneejerk "the man wants to shut this down because he can't make money on it" crap as with tons of other drugs. Anyone with a brain should realize by now that corporations monetize everything, period.
|
|
#
¿
Feb 10, 2018 01:39
|
|
|
sea of losers posted:right, that's why Solvay markets white widow instead of dronabinol capsules, my bad That's because weed is nationally illegal still. No poo poo you're going to stick to easier-to-defend isolates and compounds when you know that'll make it easier to make money.
|
|
#
¿
Feb 10, 2018 04:30
|
|
|
PT6A posted:No, capital must not be allowed to enter the market. There should be no profit motive in the provision of drugs. We've already seen the harm this has done with alcohol and tobacco, and we might soon see it with marijuana, and arguably the only reason those substances should remain as regulated free markets is that there are qualitative differences between brands/products beyond the active chemicals. Retail weed's been going in the US for a while now, nothing bad has happened from it.
|
|
#
¿
Dec 3, 2018 04:29
|
|
|
So how are the "number of prescriptions per x people" figures determined anyway? Are they prescriptions per year, or month, some other time? Do we count both 3 pills as a one-off from a surgery as equal to a 30 day supply to someone who's been on them for 5 years straight? And when you start comparing between countries, there's stuff like how certain preparations of codeine are available over the counter in the UK but would need a prescription in the US.
|
|
#
¿
Dec 10, 2018 05:52
|
|
|
pangstrom posted:What country are you proposing even gets close, fishmech. I'm trying to ask what's being measured with that number in the first place, dude.
|
|
#
¿
Dec 10, 2018 06:01
|
|
|
|
| # ¿ May 12, 2024 15:00 |
|
|
pangstrom posted:I'm trying to ask which country would even come close regardless of how you measure it, dude. That would require us to know what is being counted!
|
|
#
¿
Dec 10, 2018 06:05
|
|